Plasmodium falciparum circumsporozoite protein (CSP) is critical for sporozoite function and invasion of hepatocytes. Given its critical nature, a phase III trial evaluating a CSP based malaria vaccine is ongoing. The CSP is comprised of three regions: an aminoterminus that binds heparin sulfate proteoglycans, a four amino acid repeat region (NANP) and carboxyl-terminus which contains a thrombospondin-like type I repeat (TSR) domain.
The structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate These mAbs recognized all rCSPs, indicating the rCSPs contain a properly folded TSR domain structure. Characterization of both EcCSP and PpCSP by dynamic light scattering and velocity sedimentation demonstrated that both forms of CSP appeared as highly extended proteins (R h 4.2 nm and 4.58 nm, respectively).
Further, high-resolution atomic force microscopy revealed flexible, rod-like structures with a ribbon-like appearance. Using this information, we modeled the NANP repeat and TSR domain of CSP. Consistent with the biochemical and biophysical results, the repeat region formed a rod-like structure about 21 Ongoing multifaceted global intervention strategies to control malaria include drug treatment, insecticide usage, bed-net use, and vaccine development. However, parasite and mosquito control measures have met with limited success resulting from an increased drug and insecticide resistance within the Plasmodia and mosquito populations, respectively. Vaccine development represents an encouraging approach given that previous animal and human studies using irradiated sporozoites demonstrated the feasibility of producing an efficacious vaccine (1) (2) (3) . While the exact immunologic correlates of protection remain elusive, an abundance of evidence indicates that protection against liver stage parasites is complex, involving multiple immune mechanisms (4) (5) (6) (7) (8) (9) (10) (11) .
To date the majority of the preerythrocytic stage vaccine development has focused on the circumsporozoite protein (CSP), the predominant surface antigen on sporozoites. CSP can be segmented into three regions: the Nterminal region containing region I; the central repeat region; and the C-terminal region containing the thrombospondin-like type I repeat (TSR). Initial CSP vaccine development focused on the central repeat region which contains the immunodominant B cell epitope (12) . However, vaccine constructs quickly evolved to incorporate both the central repeat region containing the B-cell epitopes and the C-terminus containing the TSR domain, T-cell epitopes and B-cell epitopes (13, 14) .
Currently, the most advanced and moderately effective malaria vaccine, RTS,S, is comprised of a portion of the central repeat and the C-terminal regions linked to the hepatitis B surface antigen (15). However, recent studies have highlighted the physiological importance of the N-terminal region (16) (17) (18) (19) . Rathore et.al. (2002) not only demonstrated the role of the Nterminal region in liver cell attachment but also identified along with Ancsin and Kisilevsky (2004) an epitope within the N-terminal region that interacted with liver cells through heparin sulfate (16, 18, 19) . Moreover, this epitope was not only found to be immunogenic, but the resulting antibodies were determined to be inhibitory in a sporozoite invasion assay (18) . Peptides corresponding to the N-terminal region (PpCS and PpCS ) were also recognized by sera obtained from individuals living in malariaendemic regions (17) .
In order better understand the structure of CSP, as well as, produce good quality recombinant protein for human vaccine directed studies, we generated full-length and near full-length recombinant CSP. We examined two expression systems, Escherichia coli (Ec) and Pichia pastoris (Pp), to determine their feasibility to generate CSP. To assist the characterization of the rCSPs, we generated a panel of monoclonal antibodies (mAbs) which were characterized biologically prior to being used to examine the rCSPs. Additionally, each of the rCSP molecules was extensively biochemically and biophysically characterized. The results collated together have enabled the molecular modeling of CSP as a long flexible, rod-like protein.
Experimental Procedures
Antibody production-To generate antibodies toward CSP, we utilized a Saccharomyces cerevisiae expressing CSP (ScCSP) clone generated by David Kaslow (unpublished data). The 3D7 DNA sequence (GenBank accession no. XM_001351086) corresponding to CSP amino acids Phe 20 to Ser 384 was cloned into the Saccharomyces expression vector YEpRPEU3 using the cloning sites NheI and ApaI. The resulting transcribed gene contained a 6-HIS tag. The sequence of CSP was verified prior to fermentation.
Fermentation material was produced as described in (20) and purified using a two step purification scheme: Nickel Affinity Chromatography followed by Size Exclusion Chromatography. Louis, MO), 1% 100X L-glutamine and 1% Penicillin/Streptomycin (10,000 U/ml) (Invitrogen Corp., Carlsbad, CA). In preparation for seeding, HepG2 cells were trypsinized, washed and resuspended in ECM to a final concentration of 300,000 cells/ml.
After aspiration of ECL solution, 300 μl of the HepG2 cell suspension was added to each well and incubated O/N at 37°C.
Pf sporozoites (strain NF54), were grown in Anopheles stephensi adult female mosquitoes until harvest. Mosquitoes were collected in a cylindrical chamber, placed at -20°C for 5-10 minutes and soaked in 70% ethanol. They were then serially washed in DMEM medium (Invitrogen, Carlsbad, CA) containing Penicillin/Streptomycin plus AntibioticAntimycotic (Invitrogen, Carlsbad, CA) and ECM. Each mosquito was dissected by separating the head from the thorax and removing the salivary glands from the head and/or thorax. The salivary glands were stored in ECM at room temperature (RT) until use.
After all mosquitoes were dissected, the salivary glands were pooled and disrupted by passing through a 28½ -gauge needle. The sporozoites released from the salivary glands were counted and diluted in ECM to a final concentration of 500,000 sporozoites/ml.
ISI Assay: Sporozoite invasion of HepG2 cells and preparation of HepG2 cells/parasites for RNA isolation-
Each serum sample to be tested was diluted in ECM to 2X the desired final concentration.
The anti-sporozoite (CSP) antibody, navy falciparum sporozoite antibody 1 (NFS1) (developed by immunizing mice with whole sporozoites), used as a positive control, was diluted to a concentration of 200 μg/ml. For each well, fifty five μl of the test or control serum was mixed with 55 μl of the sporozoite suspension and incubated at RT for 20 min. Old medium was aspirated, and then 100 μl of each sporozoiteserum mixture was added to each well and incubated for 3 hrs at 37°C. After the 3-hr invasion incubation, each well was washed twice with fresh ECM and incubated overnight (15-21 hrs) at 37°C.
To generate a standard curve for the qRT-PCR, sporozoites were serially diluted in ECM (4,860 to 20 sporozoites), added to HepG2 monolayers. Total host-cell/parasite material was collected and stored at -80°C until RNA extraction. Following an overnight incubation at 37C, HepG2 cells were washed at RT, trypsinized at 37C, and transferred to an RNase-free microcentrifuge tube. Free sporozoites were removed by twice pelleting the host cells at 1500 rpm for 2 minutes. The pellet was stored at -80°C or used directly for RNA extraction.
ISI Assay: RNA extraction and quantitative realtime PCR (qRT-PCR)-RNA was extracted and isolated from host cell/parasite material using the RNeasy Mini Kit (Qiagen, Valencia, CA), and RNA quality assessed in a GeneQuant Pro DNA/RNA Calculator (GE Healthcare, Piscataway, NJ) using Quartz Capillaries (GE Healthcare, Piscataway, NJ). Only RNA with an A260/280 ratio greater than 1.9 was used in further experiments. RNA was uniformly diluted to <100 ng/ml, added to PCR reaction plates then transcribed to cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA). Reaction volumes of 20 μl were used in a Thermal Cycler (MJ Research Inc., Waltham, MA) set at the following amplification cycle: 25°C for 10 min; 37°C for 120 min; 85°C for 5 sec; hold at 4°C. The resulting cDNA was used immediately or stored at -20°C.
The following probe and primers were used to detect parasite 18S rRNA: Taqman® Experimental samples were compared to the standard curve generated from host cell / sporozoite mixtures containing known numbers of sporozoites. The percent inhibition was determined by comparing the number of sporozoites invaded after mAb treatment with the number of sporozoites invaded without mAb treatment.
SDS-PAGE and Western
Blot-Sporozoite extract, equivalent to approximately 2 × 10 6 sporozoites per lane, was loaded onto a 4-12% gradient BisTris gel under reducing and non-reducing conditions. Samples analyzed under reduced conditions were either mixed with dithiothreitol (DTT) (Sigma) at a final concentration of 50mM (reduced) or mixed with DTT followed by treatment with Iodoacetamide (Sigma) at a final concentration of 200mM (reduced and alkylated).
Following the electrophoretic separation, proteins were transferred onto a nitrocellulose membrane for immunoblotting using standard methods (22, 23) . All washes were performed in 1x PBS with 0.5% Tween 20. Development of the membrane was performed by incubating the nitrocellulose membrane with 0.5 µg/ml purified IgG from the CSP specific mAbs diluted in blocking buffer (1x PBS, 0.5% Tween 20, and 5% skim milk). Primary antibody was detected with goat anti-mouse alkaline phosphatase-conjugated secondary antibody. Detection was achieved using the BCIP/NBT 1-component phosphatase substrate (KPL, Kirkegaard & Perry Laboratories Inc., Gaithersburg, Maryland), as per manufacturer's instructions. SDS-PAGE analysis of recombinant protein was performed on 4-12% gradient Bis-Tris polyacrylamide gels (Bio-Rad) under non-reducing and reduced/alkylated conditions. Immunoblotting was performed as described above using 4-12% gradient Bis-Tris polyacrylamide gels (Bio-Rad) under nonreducing, reducing and reduced/alkylated conditions.
Immunofluorescence Assay (IFA) and Confocal
Microscopy-IFA analysis was performed as per standard protocol (24) . Sporozoites collected by Ozaki method were washed with RMPI and incubated with blocking media (1x PBS, 3% BSA) at 4ºC (25) . All primary and secondary antibody incubations were carried out at 4ºC separated by extensive washing with PBS containing 0.05% Tween-20 (Bio-Rad). The samples were mounted under coverslips using Vectashield hard-set mounting medium then stored at 4°C until images were acquired by confocal microscopy as described previously (24) . A Leica SP2 confocal microscope using Leica confocal software was used for image acquisition. All images were collected by using a PL APO ×100/1.4 oil immersion objective and a confocal zoom of ×6. Alexa 488 conjugate wase excited by an Argon laser (488 nm). All images were collected as 3-D data sets (z-stacks) with a step size of 0.1221 nm between the successive optical sections. Deconvolution of all image stacks was performed using Huygens Essential (Scientific Volume Imaging) to improve the maximum resolution of the data, as well as to minimize background noise. Deconvolved images were saved and analyzed through Imaris image analysis software (version 5.7.2, Bitplane). Confocal images in this study are displayed as maximum projection of the 3D image stacks.
Expression and Production of EcCSP-
The amino acid sequence of CSP (Indian isolate, GenBank accession no. AAN87606) was used to generate a codon optimized synthetic gene for expression in E.coli (GeneArt, Regensburg, Germany). The construct, corresponding to amino acids 19 L to 411 S of the full length CSP, was subcloned into the E.coli pET-24a+ expression vector downstream of the T7 promoter using the NdeI and XhoI restriction sites (EMD Chemicals Inc., Gibbstown, New Jersey). The resulting transcribed gene incorporates the additional amino acid sequence LEHHHHHH.
Recombinant EcCSP was expressed using E.coli BL21(DE3) cells. Fermentation of BL21(DE3)-EcCSP was performed in a 5L bioreactor using defined medium at 37°C as described previously (26) . When the optical density at 550 nm reached 40 -45, the temperature was reduced to 25ºC and induced by adding isopropyl-1-thio-β-galactopyranoside (IPTG) to a final concentration of 1mM for 3 hours. Cell culture was harvested by centrifugation and stored at -80°C.
The frozen cell pellet was disrupted using either mechanical lysis or chemical lysis. For mechanical lysis, the cell pellet was resuspended in 10 volumes of lysis buffer (20mM Tris pH8.0, 100mM NaCl, 1M Urea, 5mM DTT) and passed through a microfluidizer (M110Y, Microfluidics Corp., Newton, MA) three times at 19,000 lb/in 2 . The lysate was centrifuged for 30 minutes at 10,000 x g to pellet and remove the inclusion bodies and cellular debris. EcCSP was then captured from the soluble fraction using a Nickel Sepharose Fast Flow (GE Healthcare, Piscataway, NJ) column under reducing and denaturing conditions using a buffer containing 6M Guanadine-HCl and 5mM DTT.
For chemical lysis, the cell pellet was resuspended in 10 volumes of lysis buffer (20mM Citrate, 1% SB3-12 (Sigma-Aldrich), 0.1% ABS-14 (Sigma-Aldrich), 75mM NaCl, pH 7.7) and mixed for 2hrs at RT. Following the addition of lysis buffer to the cell pellet, 25U of Benzonase (Novagen/ EMD Chemicals, Inc., Gibbstown, NJ) per ml of lysis buffer was added. The lysate was centrifuged for 30 minutes at 10,000 x g to pellet inclusion bodies and cellular debris. Inclusion bodies were washed with water then solubilized in solubilization buffer (11mM Tris, 111mM Sodium Phosphate, 6M Guanadine-HCl, pH 8.0) overnight at RT. Solubilized EcCSP was captured under reducing and denaturing conditions using a Nickel Sepharose 6 Fast Flow (GE Healthcare, Piscataway, NJ) column.
Nickel captured EcCSP was refolded on a Sephacryl S-300 HR column. A sample load of approximately 2 -3% of a column volume was loaded on a preequilibrated column with refold buffer 1 (20mM Sodium Phosphate, 50mM Guanadine-HCl, 1M Urea, 500mM Arginine, 150mM NaCl, 1mM EDTA, 1mM DTT, pH 7.2) and eluted from the column using refold buffer 2 (20mM Sodium Phosphate, 1M Urea, 500mM Arginine, 150mM NaCl, 1mM EDTA, pH 7.2). EcCSP was subsequently dialyzed and purified on a Q Sepharose HP (GE Healthcare, Piscataway, NJ) column and polished using a size-exclusion Superdex 75 (GE Healthcare, Piscataway, NJ) column.
Expression and Production of PpCSP-As with the E.coli expression of CSP, the amino acid sequence of CSP (GenBank accession no AAN87606) was used to produce a Pichia codon optimized synthetic gene for expression in the methylotrophic yeast P. pastoris (Invitrogen, Carlsbad, Ca).
A shortened CSP construct corresponding to amino acids G 86 to S 410 was cloned into the XhoI and XbaI sites of the Pichia expression vector pPICZαA as per manufacturer's instructions. The resulting transcribed gene lacked a 6-HIS tag. Prior to linearization with SacI and transformation into P.pastoris, the gene sequence of CSP was verified. Recombinant protein was produced in 5L bioreactors as described previously (22, 27) . A scalable purification process will be detailed elsewhere. However, in brief, secreted PpCSP was subjected to depth filtration (Sartorius, Goettingen, Germany), followed by capture on a CM Hyper Z column (Pall, East Hills, NY), purification by Q Sepharose HP column (GE Healthcare, Piscataway, NJ) and polished with a size-exclusion Superdex 75 column (GE Healthcare, Piscataway, NJ). The final bulk antigen was diluted to 1.0 mg/ml in saline pH 7.4, sterile filtered and stored at -80°C.
BiaCore Chip Preparation and Interaction
Studies-Surface Plasmon Resonance (SPR) measurements were performed using a Biacore 3000 biosensor, operating with the BiaCore Control software (BIAcore 3000, BIAcore AB, Sweden). All experiments were performed at 25°C.
Three kinetic binding assays were employed to ascertain the binding properties of the recombinant CS proteins. Three mAbs: 1G12, 4B3 and 4C2, were immobilized to the CM5 sensor chip using an amine coupling kit according to manufacturer's instructions (GE Healthcare, Piscataway, NJ). The CM5 chip surface was activated with an equal-molar mix of Nhydroxysuccinimide/N-ethyl-N-(dimethyaminopropyl)carbodiimide, followed by immobilization of mAbs 1G12 in 10mM HEPES pH 6.8, 4B3 in 10mM Acetate pH 6.5 or 4C2 in 10mM Acetate pH6.0. Un-reacted sites were blocked with ethanolamine (GE Healthcare, Piscataway, NJ).
Each of the mAbs were immobilized in either flow cell 2 or 4 at 600 response units, while flow cells 1 and 3 were activated then de-activated to serve as reference surfaces. For the interaction studies, recombinant CS proteins were serially diluted in HBS buffer (GE Healthcare, Piscataway, NJ) at concentrations from 10nM to 1µM. Samples were injected at a flow rate of 30µl/min for 2 minutes. The sensor chip was regenerated using 2 injections at 30µl/min of 10mM Glycine pH 3.0 for 30 seconds and 10 seconds with a 2 minute stabilization period. Data were analyzed using BiaEvaluation (GE Healthcare, Piscataway, NJ) and fit a 1:1 model.
For the indirect kinetic analysis, mAb 4B3 was immobilized on a CM5 chip as previously stated. CS protein was diluted in HBS buffer to a concentration of 100 nM. CS protein was injected as stated above. 4C2 and 1G12 were diluted in HBS buffer at two concentrations, 50 and 500 nM and injected similarly to the CS protein. The sensor chip was regenerated using 2 injections at 30µl/min of 10mM Glycine pH 3.0 for 30 seconds and 10 seconds with a 2 minute stabilization period. As a negative control, 4C2 was diluted to 50nM, 10 times the K D , and injected as stated above.
Circular Dichroism-To examine secondary structure, samples in 1x PBS were diluted 1:10 in deionized (MilliQ) water. CD spectra were recorded over the wavelength range 185 -260 nm in a 1 mm path-length quartz cuvette using a step size of 0.2 nm, a slit bandwidth of 1.0 nm and a signal averaging time of 1.0 second. Analysis of temperature on secondary structure was performed in 5ºC temperature increments from 5ºC to 80ºC. Secondary structure content was calculated using the DICHROWEB web server (http://dichroweb.cryst.bbk.ac.uk) (28, 29) . (30) .
SEC-MALS-QELS-HPLC-

Analytical ultracentrifugation characterization of
EcCSP and PpCSP-Boundary sedimentation velocity (SV) measurements were made in Optima XLA analytical ultracentrifuge (Beckman-Coulter Instruments). SV analysis was performed at 20˚ C at a rotor speed of 58,000 rpm. The centrifuge cell was filled with 400l of protein solution at a concentration of 1.0 mg/ml of PpCSP or EcCSP.
Absorbance scans were obtained at 235 nm. Sedimentation coefficient distribution analysis to deconvolute the boundary velocity data into sedimenting species was performed as previously described (31) , using the public domain software Sedfit developed by Peter Schuck (http://www.analyticalultracentrifugation.com/ ). The result of this computational analysis is a presentation of the distribution of sedimenting species in the form of a c(s) vs. s plot. In this computational treatment, the sedimentation boundary velocity data were subjected to maximum entropy regularization statistical analysis for the most parsimonious distribution of sedimenting species (31) that best fits the data. A weight average shape factor (f/f o ) is extracted from the boundary spreading and this allows for the conversion of the c(s) vs. s distribution to a c(M) vs. M graphical presentation, thereby providing the molar mass of each sedimenting peak. The software program Sednterp developed by Hayes, Laue, and Philo (http://www.bbri.org/RASMB/rasmb.html) was also used to determine the partial specific volume of the PpCSP and the viscosity () and density () for the PBS solution used in the sedimentation analyses and for the hydrodynamic analysis to be reported below.
Atomic force microscopy (AFM) -Samples for AFM were prepared and analyzed basically as described by Tsai et. al. (2009) (30) with modifications as noted. Biological AFM imaging of the protein products was carried out under a range of conditions, both in fluid and air, using gentle tapping-mode AFM, mostly with a PicoForce Multimode AFM (Veeco, CA) consisting of a Nanoscope® V controller, a type E scanner head, and a sharpened TESP-SS (Veeco, CA) or similar AFM cantilever (30, 32) . For rCSP visualization, suitable protein attachment was readily achieved by one minute incubation of 7 μl of ca 1 μg/ml solution of rCSP in PBS (pH = 7.4) buffer on freshly peeled mica substrates, followed by rinsing with ca 1 ml of deionized water and complete drying under an inert gas flow. The sample was then sealed into the instrument compartment dehumidified by Drierite® particles (30) . AFM images were evaluated within the Nanoscope software (version 7.2, Veeco, CA), and exported to Image J (version 1.41o, NIH, Bethesda, MD) and Mathcad (version 14, Mathsoft, MA) for further analyses and display.
Modeling-Tertiary structure modeling of the truncated N-terminal domain was not attempted. Secondary structure was predicted using PSIPRED (33) and JUFO (34, 35) .
The repeat region was modeled by building up experimentally determined structures of the repeating unit (NPNA). The crystal structure of Ac-ANPNA-NH2 (36) was aligned to the average NMR structure of (NPNA) 3 at each of the NPNA repeats (37) to verify the agreement between them (0.47, 0.46, 0.39 Å C RMSD). The NMR structure of (NPNA) 3 was extended by aligning residues 1-8 of a second (NPNA) 3 to residues 5-12 of the first. Repeating this procedure, (NPNA) 43 was built up, corresponding to residues 103-274 of the native CSP sequence. Mutations were introduced into the N-terminus of the repeat region to correctly model the DPNA and NPNV repeats found there. Side chains rotamers were optimized using SCWRL3 (38) .
The TSR domain was modeled using the automatic threading and homology modeling service LOMETS (39) . High confidence models were selected and evaluated for the presence of the characteristic disulfide formation of the TSR. Alignments by SAM-T02 (40), FUGUE (41), and PPA-II (39) to TSR template 1lsl (42) generated acceptable models using MODELLER (43) .
Secondary structure composition for the repeat region and the TSR domain was measured by DSSP (44) and structure analysis and visualization were accomplished using Chimera (45) and PyMOL (46) .
Results
Generation and characterization of CSP specific mAbs-In order to evaluate the folding of recombinant CSP expressed in E.coli (EcCSP) and P.pastoris (PpCSP) (Fig 1) , a panel of 18 mAbs was first screened by Western blot analysis against sporozoite lysates to identify reduction-sensitive mAbs. Representative Western blots for three of the mAbs are shown in Fig 2a. Both 1G2 and 1B3 displayed the characteristic CSP doublet banding pattern at approximately 60 kDa (47,48) on both non-reduced (NR) and reduced plus alkylated sporozoite lysates, as represented by 1G2 (Fig  2a) . These mAbs also recognize the NANP repeats (data not shown). In contrast, three other mAbs: 1G12, 4B3 and 4C2, maintained reactivity with the non-reduced sporozoite lysate, but displayed a markedly reduced interaction with the reduced and alkylated sporozoite lysate, depicted by 1G12 and 4C2 (Fig. 2a) .
To further characterize the mAbs for biological significance, the panel of mAbs was examined for reactivity to live sporozoites by confocal microscopy. All three mAbs reacted with viable sporozoites, demonstrating a characteristic surface staining. Shown in Fig. 2b are maximum projection images from confocal microscopy using mAbs 1G12, 4C2 and 1G2. Since the reduction-sensitive mAbs recognized CSP on the live parasites, we examined their ability to inhibit invasion of liver cells by live Pf sporozoites (strain NF54), where the invasion rate ranges between 0.3% -6%. 1G12, 4B3 and 4C2 exhibited inhibitory activity of sporozoite invasion of HepG2 cells (Table I) .
Expression, purification and biological characterization of EcCSP and PpCSP-Two different synthetic CSP genes were used to express CSP in E.coli and P. pastoris (Fig 1) . Following expression and purification as described in the Experimental Prodecures, two forms of refolded and purified EcCSP were generated and identified based on the lysis method, EcCSP-ML (mechanical microfluidization lysis) and EcCSP-CL (chemical detergent lysis). The integrity and purity of EcCSP-ML and EcCSP-CL, as well as the PpCSP are shown by Coomassie blue stained SDS-PAGE gel (Fig. 3a) and immunoblot (Fig.  3b) . A reduction-sensitive high molecular weight band migrating at 120 kDa is only observed in EcCSP-CL (Fig. 3a) likely due to the presence of an amino-terminal free cysteine (see below). As shown in Fig. 3b , EcCSP-ML/CL and PpCSP react with the mAb, 1G12, in a reduction sensitive manner by Western blot. Similar reactivity by Western blot using mAbs 4C2 and 4B3 was observed with all three recombinant CS proteins, EcCSP-ML/CL and PpCSP (data not shown). MAbs 1G12, 4C2 and 4B3 were also shown to react by Western blot with a protein product corresponding to the TSR domain in a reductionsensitive manner (data not shown). These three reduction-sensitive mAbs were isotyped and subclassed, and determined to be IgG 1 .
The interaction of EcCSP-ML and PpCSP with the three reduction-sensitive mAbs-1G12, 4B3 and 4C2 was further characterized by surface plasmon resonance. To examine the affinity or K D of the three mAbs: 1G12, 4B3 and 4C2, to EcCSP-ML and PpCSP, each of the mAbs were amine coupled to the surface of a CM5 chip (see supplemental figure 1a for example 4C2). The K D of the mAbs toward the two recombinant CS proteins was comparable. The affinity of the reduction-sensitive mAbs 4B3, 4C2 and 1G12 for EcCSP-ML was 8nM, 40nM and 100nM respectively. Similarly for PpCSP, the affinity of the three mAbs 4B3, 4C2 and 1G12 was 4nM, 40nM and 60nM. Analysis by surface plasmon resonance demonstrated the mAb combinations 4B3/ 4C2 and 4B3/1G12 shared an overlapping epitope (see supplemental figure 1b).
Additional biological and biophysical characterization of the three recombinant CS proteins using electrospray ionization mass spectrometry (ESI-MS), N-terminal sequencing and endotoxin concentration was performed to ascertain the identity and purity of the purified proteins.
Using reversed phase-HPLC, the primary elution peak from each of the samples was analyzed by ESI-MS ( Table 2 ). The observed mass for the non-reduced form of PpCSP was 33,078.9 Da, (Table 2) , which is within 1Da of the non-reduced theoretical mass 33,079.9 Da, indicating the biochemical integrity of the protein is good. Results obtained with EcCSP-CL showed that the observed mass is similar to the theoretical mass ( Table 2 ). Identity of both proteins was confirmed by N-terminal sequence analysis, which yielded the expected N-terminal sequence for EcCSP-CL and PpCSP (Table 2 ). Contrary to EcCSP-CL and PpCSP, the major observed mass for EcCSP-ML did not correspond to the expected theoretical mass for the designed product. Further examination based on mass spectrometry and Nterminal sequencing analyses identified a mixture of several different CSP species with aminoterminal truncations (Table 2) . Analysis for endotoxin concentration of our purified proteins showed endotoxin levels ranged between 5EU/mg and 68 EU/mg (Table 2) .
Biophysical and Biochemical Characterization of EcCSP and PpCSP: Circular Dichroism (CD)
spectroscopy and thermal stability-CD spectra of purified PpCSP and EcCSP were generated to examine their secondary structures. Analysis of the far UV spectra for secondary structure outputs for PpCSP using the Dichroweb server (28, 29) indicated PpCSP was comprised of 10% ± 4% α-helix, 23% ± 7% β-sheet, 17% ± 5% β-turn and 49 ± 13% random structure. Similar spectral results were obtained for both of the EcCSPs. All three recombinant proteins were evaluated for changes in secondary structure due to heating by a step procedure that generated a temperature ramp in 5ºC increments, beginning at 5ºC and ending at 80ºC. As shown in Figure 4 , a change in the secondary structure of PpCSP was observed with increased temperature as indicated by increased intensity in negative ellipticity between 215 and 235 nm and a decrease from 190-215 nm (Fig 4) . The reversibility of the temperature induce secondary structure transitions was shown by the cooling back to either 5ºC or 20ºC from 80ºC, where secondary structure was reformed, as indicated by a shift in the ellipticity spectra of the heated samples back toward the original 5ºC spectra. Similar results were also obtained for EcCSP-ML and EcCSP-CL (data not shown). The spectra for PpCSP in the near-UV, 250 -320 nm, showed very little signal, which is indicative of a low amount of tertiary structure (data not shown). These results were consistent with results obtained from EcCSP-ML and EcCPS-CL (data not shown).
Biophysical and Biochemical Characterization of EcCSP and PpCSP: SEC-MALS-QELS-HPLC-
Each of the three recombinant CS proteins was examined by analytical SEC-MALS-QELS-HPLC to determine solution state, molar mass and hydrodynamic radius. Analysis of PpCSP by SEC-HPLC indicated 93.6% of the protein was monomeric in solution with 6.4% product related impurities. Examination of the EcCSPs by SEC-HPLC indicated EcCSP-ML was comprised of two populations, a monomer population at 79.6% and a dimer population at 20.4%, whereas EcCSP-CL was composed of two additional species, yielding a composition of 24% aggregates, 33% dimer, 17% monomer and 26% product related degradants. Examination of the monomer peaks from SEC-HPLC reveals PpCSP, EcCSP-ML and EcCSP-CL have similar retention times (RT) ( Table 2) , similar to the RT of immunoglobulin G (158 kDa) at approximately 17 minutes (data not shown). Further analysis of the three CS proteins by in-line MALS indicated the weight average molar mass of the monomeric peaks corresponded to the theoretical mass of each protein (Table 2 and Fig 5a) .
To further characterize the recombinant CS proteins, the hydrodynamic radii (R h ) of the monomeric recombinant CS proteins were examined by QELS. The R h of PpCSP was 4.2 nm (Fig 5b) , indicating the monomeric form of PpCSP is highly extended compared to a typical globular protein like BSA (66.4 kDa) for which R h  3.4 (30) . Similarly, the R h of EcCSP-ML was 4.7 nm. For EcCSP-CL, there was insufficient signal for the monomer to obtain a valid R h value.
Biophysical and Biochemical Characterization of EcCSP and PpCSP: Boundary sedimentation velocity characterization of PpCSP-
In order to better characterize the recombinant CS proteins, an orthogonal approach was used to determine the mass and hydrodynamic radius. Boundary sedimentation velocity was used to obtain the sedimentation coefficient distribution of the PpCSP sample. The absorbance scans of the sedimenting boundaries vs. time (data not shown) were analyzed by the computational program Sedfit to give the sedimentation distribution of protein components shown in Fig.5c (Fig. 6B) . The balance of the protein mass suggests a small amount of dimers and very sporadic occurrence of small oligomers. The protein particles are varied in shape, but all consistent with extended twisted-ribbon forms, when quantified by the number histogram of the circularity, defined as 4π•Area/(perimeter) 2 (Fig.  6C) . Assuming a straight ribbon shape for a fully extended molecule, these measured circularity values suggest the typical length to width ratio to be between two to six. Restricting to the more typical PpCSP monomers, having a measured protein volume between about 25 to 41 nm 3 , the number histogram of the molecular area is tightly distributed and falls within the range of approximately 120 to 220 nm 2 (Fig. 6D) . Taken together, the AFM images suggest an "average" ribbon shape of the dimensions around 25 nm x 7 nm x 0.2 nm for PpCSP monomers as appeared on mica surfaces. AFM imaging for EcCSP also reveals twisted-ribbon-like appearance with rodlike dimensions, but with more complex monomer-dimer-oligomerization hierarchies (data not shown). Therefore, our high-resolution AFM images fully support the interpretations of the structures deduced from the solution measurements.
Modeling of CSP-Molecular modeling as detailed within the Methods section was successful for the repeat region and for part of the TSR domain. The overall secondary structure composition for the combination of the repeat region, the TSR domain, and the truncated N-terminal domain corresponding to the EcCSP construct was about 5% α-helix, 27% β-sheet, 28% β-turn, and 36% random structure, in good agreement with the circular dichroism measurements. Stretches of about 45 residues before and after the repeat region were predicted to have little secondary structure. The TSR domain itself contains characteristic disulfide bonds between C 334 and C 369 and between C 338 and C 374 and forms an extended structure about 4.9 nm in length and 1.3 nm in width. It may be followed by a membraneassociated helix from about V 377 to the C-terminus. (Fig. 7A) . The repeat region forms a stem-like superhelix about 18 nm in length and 1.5 nm in width composed of regular β-turns with a pitch of about 28 residues or 7 repeat units (NPNA). Substitution of DPNA in the first turn of the superhelix adds a -5 formal charge to the otherwise electrically neutral structure and imparts a significant negative electrostatic potential to the N-terminus of the repeat region. (Fig. 7B, C and  D) .
Discussion
Recently, multiple vaccine trials examining the effectiveness of RTS,S, a CSP vaccine, have reported efficacy rates against infection ranging from 30% -66%, and against clinical malaria in children 1 to 4 years at 30% (49) (50) (51) . However, the RTS,S construct lacks the N-terminal region of CSP which has been shown to be a critical functional domain (16) (17) (18) (19) . Our objective was to generate and subsequently characterize recombinant CSP incorporating the N-terminus, repeat region and C-terminus, with the intention of gaining a better understanding of the struture of CSP. Here we describe the bench scale production and the extensive biological, biochemical and biophysical characterization of CSP derived from two expression systems, E.coli and P.pastoris. The recombinant products from each expression system were similar in all of the biochemical and biophysical characteristics reported here providing strong support to the conclusion that CSP is a highly extended, rod-like protein on the surface of sporozoites.
In order to biologically characterize the rCSP and to demonstrate that both EcCSP and PpCSP have structural compatibility to native CSP, we generated a panel of mAbs to purified ScCSP. The S. cerevisiae expression system was not selected for production of recombinant CSP due to low levels of expression (data not shown). To facilitate production of mAbs specific to the TSR domain of CSP, mice were boosted with a purified degraded product corresponding to the TSR domain as determined by N-terminal sequencing (data not shown). The subsequent CSP specific mAbs were screened by Western blot against sporozoite lysates, confocal microscopy of live sporozoites and a sporozoite invasion inhibition assay to determine their biological activity as well as to determine their applicability for examination of recombinant CSP conformation. The results obtained by Western blot of the sporozoite lysate demonstrated mAbs 1G12, 4B3 and 4C2 were reduction-sensitive, indicating they recognize a conformation dependent epitope (Fig 2a ) , while confocal microscopy results showed the characteristic surface reactivity to live sporozoites for the whole mAb panel (Fig. 2b) . Lastly, mAbs 1G2, 1G12, 4B3 and 4C2 were examined for their ability to inhibit sporozoite invasion of liver cells (Table 1 ). All three conformation-dependent mAbs, 1G12, 4B3 and 4C2, were able to demonstrate inhibition of liver cell invasion. These data are consistent with results published by Roggero et.al.(1995) demonstrating antibodies generated to a 102-mer peptide corresponding to the C-terminal region of CSP are able to inhibit sporozoite invasion of hepatoma cells (52) .
To assess folding of the TSR domain in the purified recombinant proteins, Western blot analysis of EcCSP-ML, -CL and PpCSP was performed using 1G12, 4B3 and 4C2 (Fig 3) . Reactivity was diminished following treatment with DTT and further reduced following subsequent treatment with iodoacetamide which prevented reformation of the disulfide bonds in the TSR domain (Fig 3) . Given that 1G12, 4B3 and 4C2 reacted similarly with native CSP (Figs 2a) , the results indicate EcCSP and PpCSP share a common conformational epitope in the TSR domain with native CSP. Further examination of the interaction between the recombinant proteins and mAbs 1G12, 4B3, 4C2 via Biacore indicated only slight affinity differences between EcCSP-ML and PpCSP with the respective mAbs, indicating both EcCSP-ML and PpCSP likely share a common structural epitope. Interaction between EcCSP-CL and the conformational sensitive mAbs was not examined using Biacore due to the propensity of EcCSP-CL to form aggregates in solution.
Biochemical characterization of purified EcCSP-ML showed that neither the N-terminal sequence nor the mass spectrum directly corresponded to the expected results. The Nterminal sequence contained a mixture of sequences (Table 2) , which is consistent with the disparity observed between the theoretical ESI-MS and the observed ESI-MS. Given that EcCSP-ML was captured from the soluble fraction following mechanical disruption of the E.coli cellular membrane, it is feasible that CSP was exposed to active E.coli proteases, which consequently led to a mixed N-terminal population of EcCSP. Subsequent modification of the lytic process from mechanical to detergent lysis lead to the production of purified EcCSP-CL for which the Nterminal sequence and ESI-MS results were comparable with the expected results.
The instability of the designed amino-terminus of EcCSP-ML may be due to the presence of the PEXEL domain that accounts for an additional proteolytic site (53) (54) (55) . This is further supported by the absence of any detectable native CSP dimers which would be expected if a free thiol was present as detected by Western blot (Fig 2) . Similar to EcCSP-CL, N-terminal and ESI-MS results for PpCSP corresponded to the designed product.
Evaluation of each of the three recombinant proteins for impurities indicated the endotoxin levels were within acceptable levels for human studies (Table 2) .
Both EcCSP and PpCSP were examined by CD in order to first examine secondary and tertiary structure. Analysis of the results from the far UV examination of both proteins using the Dichroweb server, indicates that both EcCSP and PpCSP contain very little α-helical structure, while approximately 40% of the protein is comprised of β-sheets and β-turns and 49% random structure. Inspection of both proteins in the near UV indicated very little tertiary structure. This would fit, since the only structural domain based on sequence parsimony is the TSR domain, which has an elongated anti-parallel two-β-sheet fold (42, 56) . However, more important for vaccine development is knowledge of the thermal stability or temperature effects on the structure. Examination of both proteins via a temperature ramp indicated the recombinant proteins underwent an alteration of secondary structure upon heating. Further, we sought to understand should a temperature excursion from 4ºC or room temperature occur during storage or formulation, if the secondary structure would reform upon cooling? The results for both EcCSP and PpCSP indicated secondary structure is regained following cooling from 80°C back to either 4ºC or 20°C.
Consequently, if there is a short temperature deviation, the resulting change in temperature is unlikely to have a detrimental effect on secondary structure for either recombinant protein.
Further biophysical studies of the EcCSP and PpCSP by SEC-MALS and QELS indicated a predominant monomeric solution state for both EcCSP-ML and PpCSP whereas EcCSP-CL aggregated in solution as mentioned previously. The weight average molar mass of 52 kDa for EcCSP-CL is 10kDa larger than the theoretical mass of our designed product, which is likely due to an incomplete separation between the monomer and dimer peak. Further, QELS data indicate EcCSP and PpCSP are extended molecules based on the observed hydrodynamic radii, which was corroborated by sedimentation velocity. Both QELS and sedimentation velocity data support the concept that CSP acquires a non-globular highly extended structure. To further investigate and begin to resolve the structural features of CSP, we examined all three recombinant proteins by high resolution AFM that permitted visualization of individual rCSP molecules. Such studies allowed the examination of monomeric rCSP using an orthogonal technique to both SEC-QELS and sedimentation velocity in the solution state of CSP. The AFM images and the subsequent measurements via direct visualizations on a substrate indicate that CSP is an extended linear, twisted-ribbon-like, and flexible molecule with measurements centered around 25 nm x 7 nm x 0.2 nm.
These data are the first direct evidence demonstrating CSP has an elongated structure, and are consistent with previous studies that examined the structure of the NANP repeat region of CSP. Several studies examined conformationally constrained NANP mimetics by NMR and CD (37), cyclic ANPNAA peptides by NMR (57) , and Ac-ANPNA-NH 2 peptides by crystallography (36) , all of which demonstrated the NPNA motif adopts a β-turn (58). Speculation by Nanzer et.al (1997) suggest that by affixing multiple NPNA repeats together, a stable "stem-like" structure may be formed (59) . Our SEC-MALS-QELS, sedimentation velocity and AFM data support the concept that the NANP repeat region of CSP does form a stem like structure, creating an elongated and flexible molecule. Molecular modeling also supports the stem-like nature of the repeat region ( Fig. 7a-e) . In addition to the repeat region, the TSR domain is also an elongated structure. A long linker exists between the N-terminal domain and the repeat region. Another linker exists between the repeat region and the TSR domain. These elements combine to support the experimental observations of non-globularity and multiple morphology with a three-dimensional shape of approximately 21 -25 nm x 1.5 nm x 1.5 nm. The difference between the AFM measurements versus the solution and computational measurements is partly due to compression by the AFM tip. While gentle AFM can quantitatively characterize delicate biological samples (e.g. (30, 32) , it is logical for the CSP protein with its particular elongation, flexibility and high content of random coiled structure to be visualized in the twistedribbon-like forms between the substrate and the AFM tip. Overall there is very good agreement for the relative shape in both the length and the cross sectional area of CSP between the different analytical methods.
Sporozoite entry of mammalian cells has been well studied in vitro (60, 61) and characterized as to include both traversal of cells in which no parasitophorous vacuole is formed and infection of cells accompanied by formation of a parasitophorous vacuole (62) (63) (64) (65) . However, the definitive role for the CS protein within this traversal and infection process is unclear. An abundance of evidence suggests both the Nterminal domain and C-terminal domain are involved in the invasion process of host organisms, ranging from motility to liver cell attachment via heparin sulfate proteoglycans displayed on the surface of receptors (16) (17) (18) (19) 66, 67) . How the unique structure of the CS protein as an extended, flexible rod-like structure impacts on the process of gliding, traversal or infection is worthy of further evaluation.
Here, we have generated extensively characterized rCSP expressed from two expression systems. PpCSP corresponded to our designed construct and was purified to greater than >99% purity, as determined by SEC-HPLC, without the use of an affinity tag and remained monomeric in solution following purification. These data not only present evidence of a highly purified rCSP, but they provide the first analytical evidence describing CSP as an elongated, flexible rod-like protein on the surface of sporozoites. . Raw data measured in millidegrees was converted into ellipticity (deg cm 2 /dmol). Spectra were obtained at 5ºC, 20 ºC, 80ºC and at 5ºC and 20 ºC following heating at 80ºC. Inset: The ellipticity (deg cm 2 /dmol) was plotted as a function of wavelength (nm) during heating. Spectra were obtained in 5ºC increments beginning at 5ºC, however data are presented in 10ºC increments beginning at 5ºC. The graphical image of PfAMA1 was generated from a composite of the structural data for PfAMAI and PvAMAI (PDB ID files: 2Q8A and 2J4W, respectively). The TSR domain is represented in blue, repeat region in red and the Nterminus in purple. The N-terminus depiction has been added solely to symbolize the N-terminal space. The shape of the N-terminus is a graphical illustration and is not based on structural data. 
